Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cross

Showing results (511-520 of 595) with videos related to

Pageof 60
Sort By:
Genes, Chromosomes & Cancer|January 18, 2018
Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosisNicole Naumann, Mohamad Jawhar, Juliana Schwaab, et al.
The Medical Journal of Australia|November 4, 2019
Right care, first time: a highly personalised and measurement-based care model to manage youth mental healthIan B Hickie, Elizabeth M Scott, Shane P Cross, et al.
British Journal of Haematology|January 28, 2009
Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clonesPhilip A Beer, Amy V Jones, Anthony J Bench, et al.
Journal of Cancer Research and Clinical Oncology|April 4, 2019
Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry)Susanne Möbius, Thomas Schenk, Danny Himsel, et al.
Nature Genetics|July 6, 2010
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disordersThomas Ernst, Andrew J Chase, Joannah Score, et al.
British Journal of Haematology|June 1, 2021
Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto-oncogene, receptor tyrosine kinase (KIT) D816V mutationsNicole Naumann, Johannes Lübke, William Shomali, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 19, 2020
Importance of Adequate Diagnostic Workup for Correct Diagnosis of Advanced Systemic MastocytosisJuliana Schwaab, Nicole Cabral do O Hartmann, Nicole Naumann, et al.
BMJ Open|June 10, 2020
Youth Mental Health Tracker: protocol to establish a longitudinal cohort and research database for young people attending Australian mental health servicesCathrin Rohleder, Yun Ju Christine Song, Jacob J Crouse, et al.
Haematologica|September 6, 2015
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasmsTariq I Mughal, Nicholas C P Cross, Eric Padron, et al.
Leukemia|October 7, 2021
HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusionsElspeth A Bruford, Cristina R Antonescu, Andrew J Carroll, et al.
Pageof 60

Showing results (511-520 of 595) with videos related to

Sort By:
Pageof 60
Genes, Chromosomes & Cancer|January 18, 2018
Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosisNicole Naumann, Mohamad Jawhar, Juliana Schwaab, et al.
The Medical Journal of Australia|November 4, 2019
Right care, first time: a highly personalised and measurement-based care model to manage youth mental healthIan B Hickie, Elizabeth M Scott, Shane P Cross, et al.
British Journal of Haematology|January 28, 2009
Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clonesPhilip A Beer, Amy V Jones, Anthony J Bench, et al.
Journal of Cancer Research and Clinical Oncology|April 4, 2019
Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry)Susanne Möbius, Thomas Schenk, Danny Himsel, et al.
Nature Genetics|July 6, 2010
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disordersThomas Ernst, Andrew J Chase, Joannah Score, et al.
British Journal of Haematology|June 1, 2021
Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto-oncogene, receptor tyrosine kinase (KIT) D816V mutationsNicole Naumann, Johannes Lübke, William Shomali, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 19, 2020
Importance of Adequate Diagnostic Workup for Correct Diagnosis of Advanced Systemic MastocytosisJuliana Schwaab, Nicole Cabral do O Hartmann, Nicole Naumann, et al.
BMJ Open|June 10, 2020
Youth Mental Health Tracker: protocol to establish a longitudinal cohort and research database for young people attending Australian mental health servicesCathrin Rohleder, Yun Ju Christine Song, Jacob J Crouse, et al.
Haematologica|September 6, 2015
An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasmsTariq I Mughal, Nicholas C P Cross, Eric Padron, et al.
Leukemia|October 7, 2021
HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusionsElspeth A Bruford, Cristina R Antonescu, Andrew J Carroll, et al.
Pageof 60